medical_safety_alert documents

  1. Field Safety Notices: 20 to 24 July 2026
  2. MHRA Safety Roundup: July 2026
  3. Field Safety Notices: 29 June to 03 July 2026
  4. Field Safety Notices: 27 to 31 July 2026
  5. Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
  6. Dräger Atlan Anaesthesia workstations: risk of ventilator failure (DSI/2026/005)
  7. Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35
  8. Field Safety Notices: 13 to 17 July 2026
  9. Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine Perfusion Solution): manufactured by Carnamedica (UKRP: Bridge to Life): Updated advice on the contamination of fluid DSI/2026/006 (update to DSI/2023/005)
  10. Counterfeits and unbranded copies of LifeVac anti-choking devices may fail to work correctly or worsen choking incidents if used, DSI/2024/003
  11. Class 2 Medicines Recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP, EL(26)A/33
  12. Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34
  13. MHRA Safety Roundup: June 2026
  14. Field Safety Notices: 6 to 10 July 2026
  15. UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31
  16. Class 2 Medicines Recall: Teva UK Limited, Levothyroxine 12.5mcg Tablets, EL (23)A/06
  17. Field Safety Notices: 22 to 26 June 2026
  18. Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32
  19. Class 4 Medicines Defect Notification: Brancaster Pharma Limited, Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection, EL(26)A/30
  20. MHRA Safety Roundup: May 2026
  21. Risk of severe harm from use of incorrect giving (administration) set for blood transfusion (DSI/2026/003)
  22. Field Safety Notices: 15 to 19 June 2026
  23. Class 2 Medicines Recall: Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators, EL(26)A/26
  24. Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25
  25. National Patient Safety Alert: Medical beds, trolleys, bed rails, bed grab handles and lateral turning devices: risk of death from entrapment or falls (NatPSA/2023/010/MHRA)
  26. Field Safety Notices: 8 -12 June 2026
  27. Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29
  28. M6-C Artificial Cervical Disc, Spinal Kinetics LLC: New monitoring requirements for the risk of osteolysis (DSI/2026/001)
  29. NexGen Knee replacement: affected patients should be offered additional follow up, DSI/2023/003
  30. Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, EL(26)A/28
  31. Field Safety Notices: 1-5 June 2026
  32. MHRA Safety Roundup: April 2026
  33. Field Safety Notices: 18 -22 May 2026
  34. Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe, EL(26)A/27
  35. Field Safety Notices: 27 April to 1 May 2026
  36. MHRA Safety Roundup: January 2026
  37. Field Safety Notices: 20 to 24 April 2026
  38. Field Safety Notices: 11 to 15 May 2026
  39. Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 5mg capsules, EL(26)A/11
  40. Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 10mg capsules, EL(26)A/19
  41. MHRA Safety Roundup: February 2026
  42. Field Safety Notices: 4 to 8 May 2026
  43. Field Safety Notices: 25 to 29 May 2026
  44. Class 2 Medicines Recall: Accord-UK Ltd (Trading style: NorthStar), LEVOTHYROXINE TABLETS BP 50 micrograms EL (21)A/23
  45. Class 2 Medicines Recall: Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml, EL(26)A/15
  46. Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets, EL(26)A/22
  47. MHRA Safety Roundup: September 2025
  48. Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23
  49. Allurion Gastric Balloon: Updated safety information due to the risks of gastric outlet obstruction, small bowel obstruction and gastric perforation (DSI/2026/004)
  50. Field Safety Notices: 26 to 30 January 2026